Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-25-043354
Filing Date
2025-05-14
Accepted
2025-05-14 16:30:10
Documents
13
Period of Report
2025-04-30
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 8-K ea0241575-8ka_abvcbio.htm   iXBRL 8-K/A 30226
  Complete submission text file 0001213900-25-043354.txt   205500

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abvc-20250430.xsd EX-101.SCH 3020
3 XBRL LABEL FILE abvc-20250430_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE abvc-20250430_pre.xml EX-101.PRE 22362
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0241575-8ka_abvcbio_htm.xml XML 4074
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40700 | Film No.: 25946217
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)